Surgical management and follow-up of medullary thyroid carcinoma

L. A. Marzano, A. Porcelli, B. Biondi, G. Lupoli, P. Delrio, G. Lombardi, L. Zarrilli

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Between 1977 and 1990 we operated on 33 patients with medullary thyroid carcinoma. We performed total thyroidectomy in 31 patients and central node dissection and/or lateral modified node dissection in 21 patients (63.3%). Two patients underwent radiotherapy after subtotal resection and tracheostomy. No perioperative death occurred. Twenty-five patients were followed (mean follow-up, 63.8 months) and 8 others were unavailable for follow-up. Three patients (1 with multiple endocrine neoplasia type IIB, 2 sporadic with distant metastases) died of their disease at 12, 18 and 36 months after initial operation. Of the remaining 22 patients, 4 with stage II disease were normocalcitoninemic even with pentagastrin stimulation, following total thyroidectomy and bilateral modified neck dissection and central node dissection. Eighteen other patients continued to have elevated calcitonin levels postoperatively. Only 10 patients with known cervical metastatic disease were reoperated upon. We performed extensive node dissection in all. In addition we resected recurrent tumor from the thyroid bed in 4 patients. Despite these extensive reoperations no patient became normocalcitoninemic. At the completion of the study (December 1991), 22 of the 25 patients followed were alive: 4 patients with normal calcitonin levels, baseline and after pentagastrin stimulation, and 18 with persistent mildly elevated calcitonin levels but no other evidence of disease. Our experience supports a very aggressive surgical approach at the time of the first operation for patients with medullary thyroid carcinoma. A lesser operation usually resulted in residual medullary thyroid carcinoma in the neck. We demonstrate the difficulty of achieving a cure by reoperation once the tumor becomes demonstrable by localization studies.

Original languageEnglish
Pages (from-to)162-168
Number of pages7
JournalJournal of Surgical Oncology
Volume59
Issue number3
DOIs
Publication statusPublished - 1995

Fingerprint

Dissection
Calcitonin
Pentagastrin
Thyroidectomy
Medullary Thyroid cancer
Reoperation
Multiple Endocrine Neoplasia Type 2a
Neck Dissection
Tracheostomy
Neoplasms
Thyroid Gland
Neck
Radiotherapy
Neoplasm Metastasis

Keywords

  • calcitonin
  • multiple endocrine neoplasia
  • thyroid carcinoma
  • thyroidectomy

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

Marzano, L. A., Porcelli, A., Biondi, B., Lupoli, G., Delrio, P., Lombardi, G., & Zarrilli, L. (1995). Surgical management and follow-up of medullary thyroid carcinoma. Journal of Surgical Oncology, 59(3), 162-168. https://doi.org/10.1002/jso.2930590306

Surgical management and follow-up of medullary thyroid carcinoma. / Marzano, L. A.; Porcelli, A.; Biondi, B.; Lupoli, G.; Delrio, P.; Lombardi, G.; Zarrilli, L.

In: Journal of Surgical Oncology, Vol. 59, No. 3, 1995, p. 162-168.

Research output: Contribution to journalArticle

Marzano, LA, Porcelli, A, Biondi, B, Lupoli, G, Delrio, P, Lombardi, G & Zarrilli, L 1995, 'Surgical management and follow-up of medullary thyroid carcinoma', Journal of Surgical Oncology, vol. 59, no. 3, pp. 162-168. https://doi.org/10.1002/jso.2930590306
Marzano, L. A. ; Porcelli, A. ; Biondi, B. ; Lupoli, G. ; Delrio, P. ; Lombardi, G. ; Zarrilli, L. / Surgical management and follow-up of medullary thyroid carcinoma. In: Journal of Surgical Oncology. 1995 ; Vol. 59, No. 3. pp. 162-168.
@article{898d9c4645be432f8f029239f9bbbeb3,
title = "Surgical management and follow-up of medullary thyroid carcinoma",
abstract = "Between 1977 and 1990 we operated on 33 patients with medullary thyroid carcinoma. We performed total thyroidectomy in 31 patients and central node dissection and/or lateral modified node dissection in 21 patients (63.3{\%}). Two patients underwent radiotherapy after subtotal resection and tracheostomy. No perioperative death occurred. Twenty-five patients were followed (mean follow-up, 63.8 months) and 8 others were unavailable for follow-up. Three patients (1 with multiple endocrine neoplasia type IIB, 2 sporadic with distant metastases) died of their disease at 12, 18 and 36 months after initial operation. Of the remaining 22 patients, 4 with stage II disease were normocalcitoninemic even with pentagastrin stimulation, following total thyroidectomy and bilateral modified neck dissection and central node dissection. Eighteen other patients continued to have elevated calcitonin levels postoperatively. Only 10 patients with known cervical metastatic disease were reoperated upon. We performed extensive node dissection in all. In addition we resected recurrent tumor from the thyroid bed in 4 patients. Despite these extensive reoperations no patient became normocalcitoninemic. At the completion of the study (December 1991), 22 of the 25 patients followed were alive: 4 patients with normal calcitonin levels, baseline and after pentagastrin stimulation, and 18 with persistent mildly elevated calcitonin levels but no other evidence of disease. Our experience supports a very aggressive surgical approach at the time of the first operation for patients with medullary thyroid carcinoma. A lesser operation usually resulted in residual medullary thyroid carcinoma in the neck. We demonstrate the difficulty of achieving a cure by reoperation once the tumor becomes demonstrable by localization studies.",
keywords = "calcitonin, multiple endocrine neoplasia, thyroid carcinoma, thyroidectomy",
author = "Marzano, {L. A.} and A. Porcelli and B. Biondi and G. Lupoli and P. Delrio and G. Lombardi and L. Zarrilli",
year = "1995",
doi = "10.1002/jso.2930590306",
language = "English",
volume = "59",
pages = "162--168",
journal = "Journal of Surgical Oncology",
issn = "0022-4790",
publisher = "John Wiley and Sons Inc.",
number = "3",

}

TY - JOUR

T1 - Surgical management and follow-up of medullary thyroid carcinoma

AU - Marzano, L. A.

AU - Porcelli, A.

AU - Biondi, B.

AU - Lupoli, G.

AU - Delrio, P.

AU - Lombardi, G.

AU - Zarrilli, L.

PY - 1995

Y1 - 1995

N2 - Between 1977 and 1990 we operated on 33 patients with medullary thyroid carcinoma. We performed total thyroidectomy in 31 patients and central node dissection and/or lateral modified node dissection in 21 patients (63.3%). Two patients underwent radiotherapy after subtotal resection and tracheostomy. No perioperative death occurred. Twenty-five patients were followed (mean follow-up, 63.8 months) and 8 others were unavailable for follow-up. Three patients (1 with multiple endocrine neoplasia type IIB, 2 sporadic with distant metastases) died of their disease at 12, 18 and 36 months after initial operation. Of the remaining 22 patients, 4 with stage II disease were normocalcitoninemic even with pentagastrin stimulation, following total thyroidectomy and bilateral modified neck dissection and central node dissection. Eighteen other patients continued to have elevated calcitonin levels postoperatively. Only 10 patients with known cervical metastatic disease were reoperated upon. We performed extensive node dissection in all. In addition we resected recurrent tumor from the thyroid bed in 4 patients. Despite these extensive reoperations no patient became normocalcitoninemic. At the completion of the study (December 1991), 22 of the 25 patients followed were alive: 4 patients with normal calcitonin levels, baseline and after pentagastrin stimulation, and 18 with persistent mildly elevated calcitonin levels but no other evidence of disease. Our experience supports a very aggressive surgical approach at the time of the first operation for patients with medullary thyroid carcinoma. A lesser operation usually resulted in residual medullary thyroid carcinoma in the neck. We demonstrate the difficulty of achieving a cure by reoperation once the tumor becomes demonstrable by localization studies.

AB - Between 1977 and 1990 we operated on 33 patients with medullary thyroid carcinoma. We performed total thyroidectomy in 31 patients and central node dissection and/or lateral modified node dissection in 21 patients (63.3%). Two patients underwent radiotherapy after subtotal resection and tracheostomy. No perioperative death occurred. Twenty-five patients were followed (mean follow-up, 63.8 months) and 8 others were unavailable for follow-up. Three patients (1 with multiple endocrine neoplasia type IIB, 2 sporadic with distant metastases) died of their disease at 12, 18 and 36 months after initial operation. Of the remaining 22 patients, 4 with stage II disease were normocalcitoninemic even with pentagastrin stimulation, following total thyroidectomy and bilateral modified neck dissection and central node dissection. Eighteen other patients continued to have elevated calcitonin levels postoperatively. Only 10 patients with known cervical metastatic disease were reoperated upon. We performed extensive node dissection in all. In addition we resected recurrent tumor from the thyroid bed in 4 patients. Despite these extensive reoperations no patient became normocalcitoninemic. At the completion of the study (December 1991), 22 of the 25 patients followed were alive: 4 patients with normal calcitonin levels, baseline and after pentagastrin stimulation, and 18 with persistent mildly elevated calcitonin levels but no other evidence of disease. Our experience supports a very aggressive surgical approach at the time of the first operation for patients with medullary thyroid carcinoma. A lesser operation usually resulted in residual medullary thyroid carcinoma in the neck. We demonstrate the difficulty of achieving a cure by reoperation once the tumor becomes demonstrable by localization studies.

KW - calcitonin

KW - multiple endocrine neoplasia

KW - thyroid carcinoma

KW - thyroidectomy

UR - http://www.scopus.com/inward/record.url?scp=0029054196&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029054196&partnerID=8YFLogxK

U2 - 10.1002/jso.2930590306

DO - 10.1002/jso.2930590306

M3 - Article

VL - 59

SP - 162

EP - 168

JO - Journal of Surgical Oncology

JF - Journal of Surgical Oncology

SN - 0022-4790

IS - 3

ER -